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Abstract
Chronic visceral pain is the most common complication of many functional disorders 
that do not have a defined pathophysiological cause. Functional pain syndromes include 
common disorders, such as irritable bowel syndrome (gastroenterology), chronic pelvic 
pain (gynecology), interstitial cystitis/painful bladder syndrome (urology), fibromyalgia 
(rheumatology), across multiple medical disciplines. Patients suffering from functional 
diseases may progress to cognitive decline and depression through neuroplastic changes 
not only at the level of the central nervous system but also in the periphery. Moreover, 
most functional diseases are much more prevalent in women than men suggesting estro-
gen modulation of nociceptive pathways. Defining the etiology of functional diseases for 
possible therapeutic interventions will have a significant impact on our understanding of 
observed gender differences and on improving patient’s quality of life.
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1. Introduction
Despite considerable efforts made by the medical research community and pharmaceutical 
industry to develop effective therapeutical treatments aimed to treat chronic visceral pain 
resulted from functional disease, there is little progress to date. Functional syndromes are 
estimated to affect up to 15–20% of the population worldwide. Symptom description of inter-
stitial cystitis/painful bladder syndrome (IC/PBS, urgency, frequency, and bladder pain gen-
erally relieved by voiding) is parallel to the description of irritable bowel syndrome-diarrhea 
(IBS-D) predominance (urgency, frequency and abdominal pain) relieved by defecation. 
IBS stands in contrast to a bowel’s structural disorder: unlike ulcerative colitis and Crohn’s 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the reative
Comm s Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provi ed the original work is properly cited.
disease, which are forms of inflammatory bowel disease (IBD), it does not cause changes in 
bowel tissue. The cause of functional disorders is unknown. Chronic abdominal complaints 
are without a structural or biochemical cause. Bloating, mucous in stools, diarrhea, consti-
pation or alternating diarrhea and constipation, depression, anxiety or stress are also com-
mon symptoms of IBS. Hypersensitivity of visceral primary afferent neurons could result 
from excessive production of different modulatory neurotransmitters in response to changes 
in their signal transduction pathways [1]. Nociceptors are small-to-medium size dorsal root 
ganglia (DRG) neurons, whose peripheral processes detect nociceptive physical and chemi-
cal stimuli. There is often no clear relationship between the severity of the chronic pelvic 
pain and pathology in the pelvic viscera, and there are also noticeable gender differences 
in the prevalence of functional diseases that affect more women than men. Most of studies 
in this area were focused on the central nervous system (CNS); however, our recent data 
that estrogen can gate primary afferent response to modulate nociception support the idea 
about the involvement of the peripheral nervous system (PNS) in the etiology of a wide range 
of the functional and inflammatory diseases [2]. This potentially could involve neuroplastic 
changes in primary sensory neurons and can be a novel target for therapeutic interventions 
for patients suffering from chronic visceral pain associated with functional diseases. Despite a 
successful reduction of pain using available analgesics, visceral pain relapses in most patients. 
Currently, it is a time for paradigm shift what we consider as visceral nociception, and in this 
report, author looks for possible new mechanisms of peripheral modulation of primary affer-
ent sensory neurons in development of chronic pelvic pain.
2. Neuroplasticity in peripheral nervous system
Traditionally, the main mechanism involved in development of chronic visceral pain is 
thought to be neuroinflammation. This pathway effects peripheral and central nerve sensiti-
zation and/or dysfunction of inhibitory descending pathways [3]. However, in clinical stud-
ies, visceral nociception strongly affects negative sensations that difficult to correlate with 
visceral traumata. Most nociceptive systems involved in peripheral sensitization originate in 
free sensory nerve endings of target organs that send their signals toward primary afferent 
sensory neurons within the lumbar-sacral regions of dorsal root ganglia (L1-S3 DRG).
Visceral sensitization may develop as a result of interaction between the nervous and immune 
systems. All visceral afferents can be sensitized by proinflammatory mediators, such as sero-
tonin, histamine, nitric oxide and ATP, leading to neuropathic hyperalgesia. During inflam-
mation, mast cells and leukocytes secrete inflammatory mediators such as cytokines and 
prostaglandins that activate polymodal nociceptors triggering the response of normally 
silent mechano-insensitive receptors. Mast cell mediators can also activate vanilloid receptors 
(TRPV1), purinergic (P2X
3
) and bradykinin (BK2) at PNS, causing hyperalgesia.
The serotonergic pathway, one of the main inhibitory mechanisms in the CNS, may also be 
functionally important in facilitating peripherally mediated visceral pain [4]. Most antidepres-
sants gradually increase serotonin level in the brain. Indeed, depression has been reported to 
be associated with immunosuppression. Serotonin plays a major role in the gut-brain axis by 
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modulating intestinal movement and the perception of visceral pain. An imbalance of sero-
tonin in the gut, an improper reaction of the digestive system to serotonin, or a faulty sero-
toninergic network between the gut and the brain may be a cause of depression associated 
with functional diseases. Enteric nervous systems that innervate gastrointestinal tract include 
differentiated (visceral) primary afferent neurons that innervate intrinsic and extrinsic path-
ways implicated in the pathology of many inflammatory as well as functional diseases. There 
is a noticeable correlation between inflammation induced by gut infection and symptom 
occurrence of functional disorders such as IBS [5]. New data changed the previous paradigm 
that each primary afferent neuron innervates only one viscus. The concept of viscero-visceral 
cross-sensitization is well accepted and has been documented clinically [6]. Inflammation in 
one organ can induce peripheral (in addition to central) sensitization affecting another vis-
cera. Therefore, nociceptive mechanisms involved in the progression of functional diseases 
are complicated by comorbid disorders. Both components of pain—discriminative and affec-
tive—concomitantly affect motor and cognitive systems. These systems can be gated by estro-
gen to modulate perception of pain, pain threshold and tolerance.
3. Gender differences in visceral pain
The chronic pelvic pain (CPP) from pelvic structures is more prevalent in female subjects com-
pared to males. In clinical studies, this sexual dimorphism is well recognized: the incidence of 
functional disorders is 2–3 times higher in women with IBS and even greater with IC/PBS. A 
large body of literature supports that concept indicating estrogen modulation of different 
nociceptive pathways [2]. In our previous studies, we found that estrogen receptors (ERα 
and ERβ) are present in small-to-medium size DRG neurons (presumably nociceptors) and 
ATP-sensitive DRG neurons respond to 17β-estradiol (E2) [7], which correlated well with the idea that visceral afferents are E2 sensitive. Our data clearly suggest that in addition to CNS actions, E2 can act in the periphery to modulate nociception [1]. Specifically, E2 acts in DRG neurons to modulate L-type VGCC and through group II metabotropic glutamate receptors 
[8]. One prominent way E2 modulates neuronal excitability is through the interaction with antinociceptive opioids such as enkephalins, β-endorphin and pronociceptive nociceptin/
orphanin. Furthermore, our hypothesis is that increased nociceptive input from an inflamed 
organ (i.e. uterus) sensitizes neurons that receive convergent input from an unaffected organ 
(i.e. colon). In summary, our data suggest that potential site of visceral cross-sensitivity is 
the dorsal root ganglion [9]. DRG neurons could be responsible for changes observed in the 
perception of pain during the etiology of different functional syndromes associated with pain.
Several lines of evidence indicate that E2 directly influences the functions of primary affer-ent neurons. Both estrogen receptors (ERα and ERβ) are present in DRG and visceral pain is 
affected by hormonal level in cycling females [1, 2]. Even a large body of literature supports 
the idea that E2 modulates nociceptive responses in pelvic pain syndromes, the exact mecha-nism remains unresolved. Within the context of our hypothesis, E2 modulation of nociceptive 
response depends on the type of pain, its durations and the involvement of other nociceptive-
mediated mechanisms.
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4. Primary afferent nociceptors as target in modulation of 
nociception
Visceral nociceptive signal transduction depends on type of pain (type of sensory fiber), sever-
ity, duration and effects of other endogenous nociceptive-mediated molecules. Extrinsic pri-
mary afferent fibers can be directly modulated by activation of different chemosensitive or 
mechanosensitive receptors in target organs. There are 31 pairs of polymodal nerves carrying 
sensory motor and autonomic signal transduction in human spinal cord. This information is 
further transferred to the CNS by the spinothalamic ascending pathways to the primary sen-
sory motor cortex for integration and analysis. In DRG neurons, afferent and efferent processes 
function as a single axon-proximal and distal part connected to somata as an offshoot. DRG 
first synapses with a dorsal horn neuron through the contralateral spinothalamic tract. These 
primary sensory neurons have been studied intensively in pain sensory physiology. Small-
to-medium size DRG neurons express a variety of receptors involved in pain perception such 
as ATP-sensitive P2X3, capsaicin-sensitive TRPV1 or acid-sensitive ASIC channels. Since DRG 
neurons are responsive to estrogen [10] through ERα type [11] and show sensitization, it makes 
them a suitable model to study gender differences in nociception. Interestingly, TRPV1 and 
P2X3 transduction is significantly altered during inflammatory response. DRG is also an impor-
tant site for primary afferent fiber convergence and visceral organ cross-sensitization. Even the 
role of DRG in neuromodulation of nociception is a novel topic in visceral and chronic pain, we 
hope to convince the scientific community that the DRG is an active structure rather than pas-
sive. The future studies may reveal more neuroplastic changes at the level of first-order sensory 
neurons. New hypotheses will drive translational research that should improve the outcomes 
of clinical interventions to relive patients from suffering.
5. Discussion
Pain is a complex and personal experience. Chronic visceral pain affects mood, and social 
and professional life. A delicate balance between biochemical and physiological changes and 
cognitive approaches is the most appropriate strategy to study clinical aspects of nociception. 
Pain in women can originate due to inflammation of a pelvic organ (gut, uterus and bladder) 
that can heighten the sensitivity of noninflamed organ that are innervated by the same affer-
ent neuronal pathway [12]. Commonly, the overlapping of pelvic pain occurs between the 
lower gut, uterus and urinary bladder. Common convergence of different visceral primary 
afferents onto one spinal secondary neuron transmitting signals to the supraspinal nuclei 
can either synthesize or attenuate intrinsic cellular functions via activation of P2X
3
 receptors 
by ATP and TRPV1 receptors by capsaicin within the L1-S3 DRG neurons. Furthermore, in addition to ATP, prostaglandin E2 (PGE2) is synthesized and realized during distention and 
contributes to hyperalgesia. We showed that PGE2 enhanced calcium responses induced by 
pronociceptive molecules such as ATP and capsaicin [2]. Together, our studies opened up a 
new paradigm of neuroplasticity: modulation of primary sensory neurons by sex steroids that 
may lead to structural changes within DRG. Estrogen can gate primary afferent nociceptors to 
enhance or decrease nociception.
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Pelvic pain is very subjective and thus difficult to standardize for any scientific modeling since its 
etiology affects different systems. In addition to nervous, urinary, gastrointestinal, reproductive 
and psychological systems are involved. Nociceptive behavior is highly complex: the affective 
experience leads to avoidance and often protective escape. New data will hopefully lead to the 
development of effective gender-specific therapies. Involvement of peripheral nervous system in 
mediating and/or regulating chronic visceral pain associated with nociception through structural 
and physiological changes at the level of DRG is confirmed. The new principle of neuroplasticity 
at the level of peripheral nervous system is important to understand the etiology of many chronic 
diseases associated with visceral pain (Figure 1). Peripheral sensitization at the level of primary 
afferent neurons (pain generator) leads to neuroplastic changes with major structural alterations. 
The observation that 17β-estradiol increased survival of DRG neurons [13] put this sex steroid 
hormone as potential neuroplastic modulator of sensory afferent neurons. Estradiol may act as 
transmitter molecule by changing excitability of DRG [14]. DRG neuroplasticity also contributes 
to hyperalgesia [15]. Noteworthy, treating pain can restore normal nervous system function. As 
with all new stories, the unusual concept gets most attention of medical and clinical communi-
ties. We convey the message by driving translational science into the new horizon and propose a 
multicomponent conceptual model of neuroplasticity associated with functional disorders.
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Figure 1. Conceptual model of regulatory mechanisms mediating neuroplasticity of visceral nociception at the level of 
primary afferent sensory neurons.
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